ECELLFrance Publications
2014 - 17 publications
Normalization of cerebral vasoreactivity using BOLD MRI after intravascular stenting
Attyé, A., Villien, M., Tahon, F., Warnking, J., Detante, O., and Krainik, A.
Hum Brain Mapp, 2014, 35(4):1320-4. doi: 10.1002/hbm.22255
Hum Brain Mapp, 2014, 35(4):1320-4. doi: 10.1002/hbm.22255
Pleiotrophin commits human bone marrow mesenchymal stromal cells towards hypertrophy during chondrogenesis
Bouderlique T, Henault E, Lebouvier A, Frescaline G, Bierling P, Rouard H, Courty J, Albanese P, Chevallier N.
PLoS One, 2014, 7;9(2):e88287. doi: 10.1371/journal.pone.0088287
PLoS One, 2014, 7;9(2):e88287. doi: 10.1371/journal.pone.0088287
Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia
Bura A, Planat-Benard V, Bourin P, Silvestre JS, Gross F, Grolleau JL, Saint-Lebese B, Peyrafitte JA, Fleury S, Gadelorge M, Taurand M, Dupuis-Coronas S, Leobon B and Casteilla L.
Cytotherapy, 2014, 16(2):245-57. doi: 10.1016/j.jcyt.2013.11.011
Cytotherapy, 2014, 16(2):245-57. doi: 10.1016/j.jcyt.2013.11.011
Osteoblastic differentiation and potent osteogenicity of three-dimensional hBMSC-BCP particle constructs
Cordonnier T, Langonné A, Corre P, Renaud A, Sensebé L, Rosset P, Layrolle P. and Sohier J.
J Tissue Eng Regen Med, 2014, 8(5):364-76. doi: 10.1002/term.1529
J Tissue Eng Regen Med, 2014, 8(5):364-76. doi: 10.1002/term.1529
Biotherapies in stroke
Detante O, Jaillard A, Moisan A, Barbieux M, Favre IM, Garambois K, Hommel M and Remy C.
Rev. Neurol. (Paris), 2014, 170(12):779-98. doi: 10.1016/j.neurol.2014.10.005
Rev. Neurol. (Paris), 2014, 170(12):779-98. doi: 10.1016/j.neurol.2014.10.005
CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment
Espagnolle N, Guilloton F, Deschaseaux F, Gadelorge M, Sensébé L and Bourin P.
J. Cell. Mol. Med. 2014, 18(1):104-14. doi: 10.1111/jcmm.12168
J. Cell. Mol. Med. 2014, 18(1):104-14. doi: 10.1111/jcmm.12168
Upper limb motor recovery after stroke is associated with ipsilesional primary motor cortical activity: a meta-analysis
Favre I, Zeffiro T, Detante O, Krainik A, Hommel M, Jaillard A.
Stroke, 2014; 45(4): 1077-1083. 45(4):1077-83. doi: 10.1161/STROKEAHA.113.003168
Stroke, 2014; 45(4): 1077-1083. 45(4):1077-83. doi: 10.1161/STROKEAHA.113.003168
FOXO3A Regulation by miRNA-29a Controls Chondrogenic Differentiation of Mesenchymal Stem Cells and Cartilage Formation
Guérit D, Brondello JM, Chuchana P, Philipot D, Toupet K, Bony C, Jorgensen C and Noël D.
Stem Cells Dev. 2014, 1;23(11):1195-205. doi: 10.1089/scd.2013.0463
Stem Cells Dev. 2014, 1;23(11):1195-205. doi: 10.1089/scd.2013.0463
Induction of mesenchymal stem cell differentiation and cartilage formation by cross-linker-free collagen microspheres
Mathieu M, Vigier S, Labour MN, Jorgensen C, Belamie E and Noël D.
Eur Cell Mater, 2014a, 2;28:82-96; discussion 96-7. PMID: 25179212
Eur Cell Mater, 2014a, 2;28:82-96; discussion 96-7. PMID: 25179212
Involvement of angiopoietin-like 4 in matrix remodeling during chondrogenic differentiation of mesenchymal stem cells
Mathieu M, Iampietro M, Chuchana P, Guérit D, Djouad F, Noël D and Jorgensen C.
J. Biol. Chem. 2014b, 21;289(12):8402-12. doi: 10.1074/jbc.M113.539825
J. Biol. Chem. 2014b, 21;289(12):8402-12. doi: 10.1074/jbc.M113.539825
Microvascular plasticity after experimental stroke: a molecular and MRI study
Moisan A, Favre I, Rome C, Grillon E, Naegele B, Barbieux M, de Fraipont F, Richard MJ, Barbier EL, Rémy C, Detante O.
Cereb Vasc Dis 2014; 38(5): 344-53. PMID: 25427570
Cereb Vasc Dis 2014; 38(5): 344-53. PMID: 25427570
Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy
Montespan F, Deschaseaux F, Sensébé L, Carosella ED and Rouas-Freiss N.
J Immunol Res, 2014, 2014:230346. doi: 10.1155/2014/230346
J Immunol Res, 2014, 2014:230346. doi: 10.1155/2014/230346
TNFRII polymorphism is associated with response to TNF blockers in rheumatoid arthritis patients seronegative for ACPA
Pers YM, Cadart D, Rittore C, Ravel P, Daïen V, Fabre S, Jorgensen C and Touitou I.
Joint Bone Spine, 2014, 81(4):370-2. doi: 10.1016/j.jbspin.2013.12.005
Joint Bone Spine, 2014, 81(4):370-2. doi: 10.1016/j.jbspin.2013.12.005
New preclinical porcine model of femoral head osteonecrosis to test mesenchymal stromal cell efficiency in regenerative medicine
Poignard A, Lebouvier A, Cavet M, Rahmouni A, Flouzat Lachaniette CH, Bierling P, Rouard H, Hernigou P, Chevallier NA.
Int Orthop. 2014, 38(9):1837-44. doi: 10.1007/s00264-014-2352-8
Int Orthop. 2014, 38(9):1837-44. doi: 10.1007/s00264-014-2352-8
Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels
Schelbergen RF, van Dalen S, ter Huurne M, Roth J, Vogl T, Noël D, Jorgensen C, van den Berg WB, van de Loo FA, Blom AB and van Lent PLEM.
Osteoarthr. Cartil. 2014, 22(8):1158-66. doi: 10.1016/j.joca.2014.05.022
Osteoarthr. Cartil. 2014, 22(8):1158-66. doi: 10.1016/j.joca.2014.05.022
Dysspondyloenchondromatosis without COL2A1 mutation: possible genetic heterogeneity
Tran Mau-Them F, Boualam A, Barat-Houari M, Jeandel C, Cottalorda J, Cormier-Daire V, Fabre A, Dumont B, Lefort G, Baujat G, Le Merrer M, Jorgensen C, Touitoi I and Geneviève D.
Am. J. Med. Genet. 2014, 164A(3):769-73. doi: 10.1002/ajmg.a.36331
Am. J. Med. Genet. 2014, 164A(3):769-73. doi: 10.1002/ajmg.a.36331
Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration
Veronesi E, Murgia A, Caselli A, Grisendi G, Piccinno MS, Rasini V, Giordano R, Montemurro T, Bourin P, Sensebé L, Rojewski MT, Schrezenmeier H, Layrolle P, Ginebra MP, Panaitescu CB, GOmez-Barrena E, Catani F, Paolucci P, Burns JS and Dominici M.
Tissue Eng Part C Methods, 2014, 20(3):239-51. doi: 10.1089/ten.TEC.2013.0250
Tissue Eng Part C Methods, 2014, 20(3):239-51. doi: 10.1089/ten.TEC.2013.0250